Short interest in Sage Therapeutics Inc (NASDAQ:SAGE) increased during the last reporting period, rising from 6.41M to 6.53M. This put 12.09% of the company's publicly available shares short.

Short interest for Sage Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Sage Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 919.38K shares traded per day, it would take 7.1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.